The detailed information for PTAB case with proceeding number IPR2018-00173 filed by Mylan Technologies, Inc. et al. against Noven Pharmaceuticals, Inc. et al. on Dec 4, 2017. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2018-00173
Filing Date
Dec 4, 2017
Petitioner
Mylan Technologies, Inc. et al.
Respondent
Noven Pharmaceuticals, Inc. et al.
Status
Terminated-Settled
Respondent Application Number
14024985
Respondent Tech Center
1600
Respondent Patent Number
9724310
Institution Decision Date
Jun 12, 2018

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Notice of Refund

Nov 23, 2018PAPERBOARD

Petitioner's Request for Refund

Oct 26, 2018PAPERPETITIONER

Order - 37 C.F.R. 42.5

Sep 28, 2018PAPERBOARD

Joint Motion to Expunge Exhibit 2024 Under 37 C.F.R. Section 42.56

Sep 26, 2018PAPERPATENT OWNER

DECISION Granting Joint Motion to Terminate Proceeding 35 U.S.C. § 317; 37 C.F.R. §§ 42.72, 42.74

Sep 13, 2018PAPERBOARD

Patent Owner's Updated Exhibit List as of September 5, 2018

Sep 5, 2018PAPERPATENT OWNER

Joint Motion to Terminate Proceedings

Sep 5, 2018PAPERPATENT OWNER

EXPUNGED

Sep 5, 2018EXHIBITPATENT OWNER

Joint Request to Treat Binding Term Sheet (EX2024) as Business Confidential Information

Sep 5, 2018PAPERPATENT OWNER

Patent Owner Opposition to Request for Rehearing

Jul 20, 2018PAPERPATENT OWNER

Petitioner Mylan Technologies, Inc.'s Request for Rehearing

Jul 12, 2018PAPERPETITIONER

Trial Instituted Document

Jun 12, 2018PAPERBOARD

Noven Pharmaceuticals, Inc.'s First Updated Mandatory Notice Under 37 C.F.R. Section 42.8

Jun 7, 2018PAPERPATENT OWNER

Declaration of Dr. Adrian C. Williams

Mar 13, 2018EXHIBITPATENT OWNER

Curriculum Vitae of Dr. Adrian C. Williams

Mar 13, 2018EXHIBITPATENT OWNER

Minivelle¿¿ Product Label

Mar 13, 2018EXHIBITPATENT OWNER

J. Hadgraft and R. Guy, Feasibility Assessment in Topical and Transdermal Delivery

Mar 13, 2018EXHIBITPATENT OWNER

Patent Owner Preliminary Response

Mar 13, 2018PAPERPATENT OWNER

J. Hadgraft, Passive enhancement strategies in topical and transdermal drug delivery

Mar 13, 2018EXHIBITPATENT OWNER

B. Barry, Transdermal Drug Delivery

Mar 13, 2018EXHIBITPATENT OWNER

A. Williams & B. Barry, Urea analogues in propylene glycol as penetration enhancers in human skin

Mar 13, 2018EXHIBITPATENT OWNER

Esclim Product Label

Mar 13, 2018EXHIBITPATENT OWNER

J. Mantelle, et al., Effect of Silicone/Acrylic PSA Blends on Skin Permeation

Mar 13, 2018EXHIBITPATENT OWNER

A. Williams & B. Barry, Chemical Permeation Enhancement

Mar 13, 2018EXHIBITPATENT OWNER

A. Williams & B. Barry, The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs

Mar 13, 2018EXHIBITPATENT OWNER

K. Walters & K. Brain, Dermatological Formulation and Transdermal Systems

Mar 13, 2018EXHIBITPATENT OWNER

Google Scholar search results obtained March 7, 2018 ¿¿¿ citations of Kim et al., Penetration Enhancement of ¿¿2-Selective Agonist, Tulobuterol, Across Hairless Mouse Skin

Mar 13, 2018EXHIBITPATENT OWNER

U.S. Patent No. 8,029,820

Mar 13, 2018EXHIBITPATENT OWNER

K. Brain & R. Chilcott, Physicochemical Factors Affecting Skin Absorption

Mar 13, 2018EXHIBITPATENT OWNER

A. Ghosh et al., Current Pharmaceutical Design on Adhesive Based Transdermal Drug Delivery Systems

Mar 13, 2018EXHIBITPATENT OWNER

R. Hinz et al., In vitro percutaneous penetration: evaluation of the utility of hairless mouse skin

Mar 13, 2018EXHIBITPATENT OWNER

B. Godin & E. Touitou, Transdermal skin delivery: Predictions for humans from in vivo, ex vivo and animal models

Mar 13, 2018EXHIBITPATENT OWNER

J. Bond & B. Barry, Hairless mouse skin is limited as a model for assessing the effects of penetration enhancers in human skin

Mar 13, 2018EXHIBITPATENT OWNER

R. Subedi et al., Influence of formulation variable in transdermal drug delivery system containing zolmitriptan

Mar 13, 2018EXHIBITPATENT OWNER

R. Subedi et al., Formulation and in vitro evaluation of transdermal drug delivery system for donezil

Mar 13, 2018EXHIBITPATENT OWNER

J. Mantelle, DOT Matrix Technology

Mar 13, 2018EXHIBITPATENT OWNER

J. van de Sandt et al., In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study

Mar 13, 2018EXHIBITPATENT OWNER

Petitioner's Mandatory Change-of-Information Notices

Dec 29, 2017PAPERPETITIONER

Patent Owner Mandatory Notices

Dec 21, 2017PAPERPATENT OWNER

EXPUNGED

Dec 13, 2017PAPERBOARD

Notice of Filing Date

Dec 13, 2017PAPERBOARD

EX1013 US Patent No. 5,919,477 to Bevan

Dec 4, 2017EXHIBITPETITIONER

EX1014 Ghosh

Dec 4, 2017EXHIBITPETITIONER

EX1021 US Patent No. 5,227,169 to Heiber

Dec 4, 2017EXHIBITPETITIONER

EX1023 Dinger - Noven Pharmaceuticals, Inc

Dec 4, 2017EXHIBITPETITIONER

EX1024 Butschhli - Tiny Patch 'Dots' Pharmaceutical Landscape

Dec 4, 2017EXHIBITPETITIONER

EX1027 US Patent No. 5,352,457 to Jenkins

Dec 4, 2017EXHIBITPETITIONER

EX1001 U.S. Patent No. 9,724,310 to Mantelle

Dec 4, 2017EXHIBITPETITIONER

EX1003 Brain CV

Dec 4, 2017EXHIBITPETITIONER

EX1004 US 9,724,310 File History Part 1 of 2

Dec 4, 2017EXHIBITPETITIONER

EX1004 US 9,724,310 File History Part 2 of 2

Dec 4, 2017EXHIBITPETITIONER

EX1005 US Pat Pub 20030099695 to Mueller

Dec 4, 2017EXHIBITPETITIONER

EX1006 Vivelle-Dot Label FOI Affidavit and Doc 5236149B

Dec 4, 2017EXHIBITPETITIONER

EX1007 US Pat Pub 20060078602 to Kanios

Dec 4, 2017EXHIBITPETITIONER

EX1008 Vivelle Label FOI Affidavit and Doc 5210567A

Dec 4, 2017EXHIBITPETITIONER

EX1009 US Patent No. 5,145,682 to Chien

Dec 4, 2017EXHIBITPETITIONER

EX1010 Kim

Dec 4, 2017EXHIBITPETITIONER

EX1011 US Patnt No. 5,656,286 to Miranda

Dec 4, 2017EXHIBITPETITIONER

EX1012 WO 1996003119 to Fotinos

Dec 4, 2017EXHIBITPETITIONER

EX1015 Climara - Document #5243107A

Dec 4, 2017EXHIBITPETITIONER

EX1016 Alora - Document #5210490A

Dec 4, 2017EXHIBITPETITIONER

EX1017 Menostar - Document #5228320A

Dec 4, 2017EXHIBITPETITIONER

EX1018 US Patent No. 5,902,602 to Muller

Dec 4, 2017EXHIBITPETITIONER

EX1019 US Patent No. 6,156,335 to Rovati

Dec 4, 2017EXHIBITPETITIONER

EX1020 US Patent No. 6,521,250 to Meconi

Dec 4, 2017EXHIBITPETITIONER

EX1022 Bucks

Dec 4, 2017EXHIBITPETITIONER

EX1025 van der Bijl

Dec 4, 2017EXHIBITPETITIONER

EX1026 Bronaugh

Dec 4, 2017EXHIBITPETITIONER

EX1028 US Patent No. 5,603,947 to Wong

Dec 4, 2017EXHIBITPETITIONER

EX1030 US Patent No. 6,638,528 to Kanios

Dec 4, 2017EXHIBITPETITIONER

EX1031 US Patent No. 4,624,665 to Nuwayser

Dec 4, 2017EXHIBITPETITIONER

EX1033 US Patent No. 6,024,976 to Miranda

Dec 4, 2017EXHIBITPETITIONER

EX1034 The Orange Book

Dec 4, 2017EXHIBITPETITIONER

EX1035 US 9,730,900 File History Part 1 of 2

Dec 4, 2017EXHIBITPETITIONER

EX1036 US 9,730,900 to Mantelle

Dec 4, 2017EXHIBITPETITIONER

Power of Attorney

Dec 4, 2017PAPERPETITIONER

EX1032 US Pat Pub 20090041831 to Miller

Dec 4, 2017EXHIBITPETITIONER

EX1035 US 9,730,900 File History Part 2 of 2

Dec 4, 2017EXHIBITPETITIONER

Petition for Inter Partes Review of US 9724310

Dec 4, 2017PAPERPETITIONER

EX1002 Declaration of Keith Brain, Ph.D

Dec 4, 2017EXHIBITPETITIONER